Consequently, the systematic review follows two trends of research—the role of the HER2 pathway in pancreatic carcinogenesis and the rate of HER2 positivity according to the following tumor subtypes: pancreatic adenocarcinoma, distal cholangiocarcinoma, and ampullary carcinoma. The gene discussed is ERBB2; the disease is neoplasm.